Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECARD Combination Tablets LD&HD Special Drug Use Surveillance: Long-term Use (12 Months)

NCT02016183 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02016183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECARD Combination Tablets LD&HD Special Drug Use Surveillance: Long-term Use (12 Months)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
April 1, 2009
Completion date
September 30, 2012
Enrollment
3,222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension